Key Financial Data Of Reporting Company

D.Western Therapeutics Institute, Inc. - Filing #7272873

Concept As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
Key financial data of reporting company
Business results of reporting company
Net sales
469,923,000 JPY
471,580,000 JPY
428,364,000 JPY
427,968,000 JPY
448,100,000 JPY
411,586,000 JPY
412,121,000 JPY
414,424,000 JPY
355,586,000 JPY
334,522,000 JPY
Ordinary profit (loss)
-1,178,267,000 JPY
-1,228,097,000 JPY
-796,363,000 JPY
-728,655,000 JPY
-295,806,000 JPY
-241,322,000 JPY
-39,043,000 JPY
-159,711,000 JPY
-289,527,000 JPY
-200,950,000 JPY
Profit (loss)
-1,339,857,000 JPY
-853,205,000 JPY
-386,760,000 JPY
-240,741,000 JPY
-201,927,000 JPY
Share capital
1,203,277,000 JPY
831,617,000 JPY
714,244,000 JPY
573,159,000 JPY
556,856,000 JPY
Total number of issued shares
41,625,512 xbrli:shares
32,128,012 xbrli:shares
30,871,138 xbrli:shares
29,358,600 xbrli:shares
29,251,100 xbrli:shares
Net assets
686,449,000 JPY
733,869,000 JPY
1,279,764,000 JPY
1,281,896,000 JPY
1,873,475,000 JPY
1,900,413,000 JPY
2,006,974,000 JPY
2,035,138,000 JPY
2,215,176,000 JPY
2,163,905,000 JPY
Total assets
1,615,455,000 JPY
1,669,444,000 JPY
2,373,371,000 JPY
2,371,758,000 JPY
2,956,376,000 JPY
2,973,159,000 JPY
2,427,279,000 JPY
2,462,860,000 JPY
2,780,756,000 JPY
2,737,711,000 JPY
Net assets per share
16.45
17.59
39.81
39.88
60.14
61.53
68.27
68.27
75.64
73.88
Dividend paid per share
Interim dividend paid per share
Basic earnings (loss) per share
-38.15
-36.74
-25.56
-26.85
-14.50
-13.05
-8.21
-5.08
-10.16
-7.43
Diluted earnings per share
Equity-to-asset ratio
0.424 xbrli:pure
0.439 xbrli:pure
0.539 xbrli:pure
0.540 xbrli:pure
0.628 xbrli:pure
0.639 xbrli:pure
0.826 xbrli:pure
0.814 xbrli:pure
0.796 xbrli:pure
0.789 xbrli:pure
Rate of return on equity
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Payout ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
-1,299,118,000 JPY
-586,821,000 JPY
-354,770,000 JPY
-176,306,000 JPY
-216,284,000 JPY
Net cash provided by (used in) investing activities
-10,005,000 JPY
-15,254,000 JPY
-139,890,000 JPY
-111,150,000 JPY
-13,465,000 JPY
Net cash provided by (used in) financing activities
567,628,000 JPY
134,466,000 JPY
867,297,000 JPY
-104,459,000 JPY
1,004,126,000 JPY
Cash and cash equivalents
1,126,035,000 JPY
1,867,264,000 JPY
2,334,668,000 JPY
1,933,743,000 JPY
2,308,210,000 JPY
Number of employees
19 xbrli:pure
21 xbrli:pure
21 xbrli:pure
19 xbrli:pure
20 xbrli:pure
17 xbrli:pure
16 xbrli:pure
19 xbrli:pure
13 xbrli:pure
15 xbrli:pure
Average number of temporary employees
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Total shareholder return
0.310 xbrli:pure
0.217 xbrli:pure
0.404 xbrli:pure
0.333 xbrli:pure
0.445 xbrli:pure
Total return on share price index
1.825 xbrli:pure
1.515 xbrli:pure
1.181 xbrli:pure
1.211 xbrli:pure
1.074 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.